Distinguished in Age-Related Macular Degeneration (ARMD)

Johann B. Roider

Arnold Heller Str. 3, 
Kiel, SH, DE 
Distinguished in Age-Related Macular Degeneration (ARMD)
Arnold Heller Str. 3, 
Kiel, SH, DE 
OverviewLocationsClinical Research

Overview

Johann Roider practices in Kiel, Germany. Roider is rated as a Distinguished expert by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). Their top areas of expertise are Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Vitrectomy, and Trabeculectomy.

Their clinical research consists of co-authoring 157 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 41 articles and participated in 1 clinical trial in the study of Age-Related Macular Degeneration (ARMD).

Locations

Arnold Heller Str. 3, Kiel, SH 24105, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Prophylactic Intravitreal 5-Fluorouracil and Heparin to Prevent PVR in High-risk Patients With Retinal Detachment.
Prophylactic Intravitreal 5-Fluorouracil and Heparin to Prevent PVR in High-risk Patients With Retinal Detachment.
Enrollment Status: Completed
Publish Date: April 05, 2022
Intervention Type: Drug
Study Drugs: 5-Fluorouracil, Low molecular weight heparin
Study Phase: Phase 3
A Double-Masked, Randomized, Sham-Controlled, Parallel Group, Multi-Center Study to Assess the Safety and Efficacy of Photobiomodulation (PBM) in Subjects With Dry Age-Related Macular Degeneration (AMD) (LIGHTSITE II)
A Double-Masked, Randomized, Sham-Controlled, Parallel Group, Multi-Center Study to Assess the Safety and Efficacy of Photobiomodulation (PBM) in Subjects With Dry Age-Related Macular Degeneration (AMD) (LIGHTSITE II)
Enrollment Status: Completed
Publish Date: September 02, 2021
Intervention Type: Device
Study Phase: Not Applicable
View 1 Less Clinical Trial

157 Total Publications

Specific Assay Protocols for Porcine Single-Eye Retinal Pigment Epithelium Concerning Oxidative Stress and Inflammation.
Specific Assay Protocols for Porcine Single-Eye Retinal Pigment Epithelium Concerning Oxidative Stress and Inflammation.
Journal: International journal of molecular sciences
Published: July 18, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Roider's expertise for a condition
ConditionClose
    View All 25 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile